Vefali Huseng, Manda Yugandhar, Shirani Jamshid
Department of Cardiology, St. Luke's University Health Network, 801 Ostrum Street, Bethlehem, PA, 18015, USA.
Curr Cardiol Rep. 2015 Jan;17(1):552. doi: 10.1007/s11886-014-0552-x.
Coronary artery chronic total occlusion (CTO) has rapidly become a popular target of percutaneous coronary intervention (PCI). Technical and technological advances required for approaching these anatomically complex and challenging lesions have progressed at an extraordinary pace and have led to amazing success rates. Patient selection, however, has primarily focused on patient symptoms, lesion characteristics, as well as the state of collateral circulation. Multiple national and international registries have been established to follow the progress of percutaneous CTO recanalization and have provided valuable information. Concern, however, exists that this challenging procedure will become the "standard of care" before its effectiveness and appropriateness is tested in prospective controlled trials. This manuscript reviews the current state of patient selection and the need for careful assessment of the presence and extent of myocardial viability prior to lengthy, resource-intensive, and potentially high-risk procedures.
冠状动脉慢性完全闭塞(CTO)已迅速成为经皮冠状动脉介入治疗(PCI)的热门靶点。处理这些解剖结构复杂且具有挑战性的病变所需的技术和工艺进步极为迅速,并带来了惊人的成功率。然而,患者选择主要集中在患者症状、病变特征以及侧支循环状况。已经建立了多个国家和国际登记处来跟踪经皮CTO再通的进展,并提供了有价值的信息。然而,人们担心在其有效性和适用性在前瞻性对照试验中得到检验之前,这个具有挑战性的手术将成为“标准治疗方法”。本文综述了患者选择的现状,以及在进行冗长、资源密集型且潜在高风险的手术之前,仔细评估心肌存活情况的必要性。